You are here

Article info

Article menu

Download PDFPDF

Editorial
Do patients with obstructive sleep apnoea deserve new dedicated antihypertensive strategies?
Free

Authors

  • Renaud Tamisier HP2 Laboratory, Inserm, Univ. Grenoble Alpes, Grenoble, France Pôle Thorax et Vaisseaux, Grenoble Alpes University Hospital, Grenoble, France PubMed articlesGoogle scholar articles
  • Patrick Lévy HP2 Laboratory, Inserm, Univ. Grenoble Alpes, Grenoble, France Pôle Thorax et Vaisseaux, Grenoble Alpes University Hospital, Grenoble, France PubMed articlesGoogle scholar articles
  • Jean-Louis Pépin HP2 Laboratory, Inserm, Univ. Grenoble Alpes, Grenoble, France Pôle Thorax et Vaisseaux, Grenoble Alpes University Hospital, Grenoble, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Renaud Tamisier, Laboratoire EFCR, CHU de Grenoble, CS 10217, 38043 Grenoble cedex 09, France; rtamisier{at}chu-grenoble.fr
View Full Text

Citation

Tamisier R, Lévy P, Pépin J
Do patients with obstructive sleep apnoea deserve new dedicated antihypertensive strategies?
Thorax 2017;72:495-497.

Publication history

  • First published March 6, 2017.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/